Word on the Street
"At the end of the day, the fundamentals of a company are what matters to investors."
– Alan Auerbach, CEO of Puma Biotechnology Inc., arguing that it doesn't matter whether a firm goes public via IPO or reverse merger
"We don't want everyone going public. That's bad for business."
– Matthew Perry, of Biotechnology Value Fund, explaining that good companies can always IPO, but an "IPO window" means bad companies are getting out
"I think you still need the mad scientist type CSO. You can't rent that person out."
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter